DENND1A Activators
Forskolin, by escalating levels of cAMP, triggers protein kinase A (PKA) activation, which can lead to the phosphorylation of proteins within the endocytic pathway, a process that DENND1A plays a role in. A similar effect on signaling pathways is seen with AICAR, which activates AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis, influencing vesicular trafficking. PMA engages protein kinase C (PKC), which has been implicated in a wide range of cellular functions including regulation of endocytosis and membrane trafficking, potentially interacting with DENND1A-regulated pathways.
Genistein, a tyrosine kinase inhibitor, and epidermal growth factor (EGF), through its receptor activation, modulate a complex network of signaling that is crucial for endocytic pathway regulation. These pathways are significant for DENND1A's role in clathrin-mediated endocytosis. Ionomycin, by altering intracellular calcium levels, affects proteins like calmodulin and can influence DENND1A's activity indirectly by modulating related trafficking processes. Compounds such as N6-Benzoyl- Sodium Salt, a cAMP analog, U73122, a phospholipase C inhibitor, and Monensin, a disruptor of Golgi apparatus function, demonstrate the ability to alter the signaling milieu within cells, potentially creating conditions that could affect DENND1A's functionality. Inhibiting GTPases like Cdc42 and Rac1 with ML141 and NSC23766, or the Rho-associated protein kinase (ROCK) with Y-27632, could potentially influence actin cytoskeleton dynamics, which is closely linked to DENND1A's activity in vesicular trafficking.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMPK, which can modulate trafficking pathways; AMPK activation can lead to phosphorylation of proteins that may interact with DENND1A. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which can phosphorylate proteins within the endocytic pathway that might modulate DENND1A function. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases, which can lead to altered signaling pathways and potentially influence DENND1A's role in membrane trafficking. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, which can affect calmodulin and calmodulin-dependent kinase II, potentially influencing DENND1A-associated trafficking. | ||||||
Adenosine 3′,5′-cyclic Monophosphate, N6-Benzoyl-, Sodium Salt | 30275-80-0 | sc-300167 | 10 µmol | $324.00 | 1 | |
A cAMP analog that activates PKA; can influence pathways that regulate membrane trafficking where DENND1A functions. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Disrupts Golgi function, which can affect intracellular trafficking and potentially alter the functional context in which DENND1A operates. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
A potent and selective inhibitor of Cdc42 GTPase, which can impact actin dynamics and membrane trafficking processes relevant to DENND1A's GEF activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits Rho-associated protein kinase (ROCK), potentially altering actin dynamics and vesicle trafficking pathways that could engage DENND1A. | ||||||